Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Uromed

This article was originally published in The Gray Sheet

Executive Summary

Firm's CaverMap prostate surgical aid, AlloSling tissue graft, and line of brachytherapy introduction insertion needles are exhibited at the recent American Urological Association annual meeting in San Diego. CaverMap, intended to assist in impotence prophylaxis during prostate surgery, assists the location and stimulation of cavernosal nerves. AlloSling, a pre-harvested natural tissue graft material, is used with the Needham, Massachusetts firm's 510(k) cleared Access instruments in female incontinence-correcting sling procdures. The radioactive brachytherapy introduction needles, manufactured by a third party, are intended to pave the way for the third-quarter launch of Uromed's I125 prostate cancer therapy device
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel